State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 335 actively recruiting studies with Michigan sites out of 335 registered in total. The busiest research areas in Michigan are Endometrial Cancer, Advanced Solid Tumors, Heart Failure. Leading sponsors running trials in the state include University of Michigan, AstraZeneca, SWOG Cancer Research Network. By stage, Michigan trials break down as Phase 1 (66), Phase 2 (101), Phase 3 (90), Phase 4 (14).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 335 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 335. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Endometrial Cancer, Advanced Solid Tumors, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT07085338 Phase 2
Recruiting
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunot...
Condition
Neuroblastoma Recurrent
Enrollment
54 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
NCT07493265 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Condition
Narcolepsy
Enrollment
64 pts
Location
United States, Belgium, Canada
Sponsor
Eisai Inc.
NCT07630155 N/A
Recruiting
Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope ...
Condition
Renal Pelvis and Ureter Urothelial Carcinoma
Enrollment
10 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT06047626 N/A
Recruiting
Living Well With Lymphoma
Condition
Lymphoma
Enrollment
100 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT04752774 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With...
Condition
Spasticity
Enrollment
240 pts
Location
United States, Austria, Bulgaria
Sponsor
Ipsen
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Struct...
Condition
Heart Failure
Enrollment
200 pts
Location
United States, Canada, Germany
Sponsor
Novo Nordisk A/S
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
NCT05535166 Phase 2
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With...
Condition
Medulloblastoma
Enrollment
130 pts
Location
United States
Sponsor
St. Jude Children's Research H
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
NCT06885281 Phase 1, Phase 2
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
Condition
Solid Tumors
Enrollment
166 pts
Location
United States, China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
NCT06699056 N/A
Recruiting
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ...
Condition
Ventricular Ejection Fraction
Enrollment
2,000 pts
Location
United States
Sponsor
Peerbridge Health, Inc
NCT04812366 Phase 2
Recruiting
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Pr...
Condition
Prostate Cancer
Enrollment
315 pts
Location
United States, Canada
Sponsor
University of British Columbia
NCT07215702 Phase 2
Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Parti...
Condition
Sepsis
Enrollment
124 pts
Location
United States, Argentina, Belgium
Sponsor
AstraZeneca
NCT02235857 N/A
Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmen...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
35 pts
Location
United States
Sponsor
Kaneka Medical America LLC
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT05698212 Phase 2
Recruiting
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometrio...
Condition
Endometriosis
Enrollment
75 pts
Location
United States
Sponsor
Hera Biotech, Inc.
NCT05856981 Phase 1
Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
130 pts
Location
United States, Belgium, Spain
Sponsor
Sairopa B.V.
NCT05498207 N/A
Recruiting
Identification of Biomarkers for Stress Vulnerability and Resilience
Condition
Healthy
Enrollment
500 pts
Location
United States
Sponsor
University of Michigan
NCT06880692 N/A
Recruiting
The Tick App: Changing Behaviors With Educational Messaging
Condition
Tick Bites
Enrollment
40,000 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerat...
Condition
Multiple Myeloma
Enrollment
149 pts
Location
United States, France, Spain
Sponsor
Regeneron Pharmaceuticals
Page 1 of 14 — 335 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology